Potential for unknown long-term side effects Currently, there is limited evidence regarding the long-term safety and effectiveness of microdosing protocols for tirzepatide
2 In addition to lifestyle modifications (diet and exercise), many pharmacologic strategies have been proposed to counter iatrogenic weight gain, including appetite suppressants (eg, pro-dopaminergic agents such as phentermine, stimulants, and amantadine), pro-anorectant anticonvulsants (eg, topiramate or zonisamide), opioid receptor antagonists (eg, olanzapine/samidorphan or naltrexone) and oral hypoglycemics such as metformin
Same-day administration: Both compounds can be injected on the same day
In mammalian cells, there are five isozymes (ACSL 1, ACSL 3, ACSL4, ACSL5, ACSL6), and different isozymes play different roles in different tissues
Researchers believe that dual action may help explain why tirzepatide produced greater average weight loss and blood sugar improvements than semaglutide in some clinical trials
